Citadel Advisors »

Amylyx Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $38M 2.6M 14.72
2023-09-30 $27M 1.5M 18.31
2023-06-30 $22M 1.0M 21.57
2023-03-31 $13M 426k 29.34
2022-12-31 $7.3M 197k 36.95
2022-06-30 $21M 1.1M 19.26
2022-03-31 $6.4M 502k 12.85